Geratherm Medical AG (DE:GME)
XETRA:GME
Top Page
Geratherm Medical
(XETRA:GME)
Select Model
Select Model
Rating:60Neutral
Price Target:
€3.00
▲(4.90% Upside)
Action:ReiteratedDate:11/19/25
Geratherm Medical's overall stock score is driven by its mixed financial performance and bearish technical indicators. The company's strong balance sheet and improving cash flow are positive, but declining revenue growth and bearish market momentum are concerns. The attractive valuation with a low P/E ratio and good dividend yield provides some upside potential.
Positive Factors
Balance Sheet Strength
A very low debt-to-equity ratio indicates conservative leverage and a solid equity base. That durability supports funding operations, R&D or tender participation without raising excessive debt, giving the business financial flexibility to navigate healthcare cycles over months to years.
Negative Factors
Declining Revenue Growth
Material year-over-year revenue contraction signals persistent demand or market-share weakness. Sustained top-line decline makes it harder to leverage fixed costs, constrains reinvestment capacity and raises the bar for management to restore organic growth over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A very low debt-to-equity ratio indicates conservative leverage and a solid equity base. That durability supports funding operations, R&D or tender participation without raising excessive debt, giving the business financial flexibility to navigate healthcare cycles over months to years.
Read all positive factors
Geratherm Medical (GME) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€15.25M
Dividend Yield3.46%
Average Volume (3M)4.33K
Price to Earnings (P/E)―
Beta (1Y)0.75
Revenue Growth-23.48%
EPS GrowthN/A
CountryDE
Employees179
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.03
Shares Outstanding5,444,998
10 Day Avg. Volume3,658
30 Day Avg. Volume4,334
Financial Highlights & Ratios
PEG Ratio-0.70
Price to Book (P/B)0.90
Price to Sales (P/S)0.92
P/FCF Ratio15.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.06
Revenue Forecast (FY)€19.10M
Geratherm Medical Business Overview & Revenue Model
Company Description
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers...
How the Company Makes Money
Geratherm Medical generates revenue through the sale of its medical devices and related services. The primary revenue streams come from direct sales of its products to hospitals, clinics, and healthcare providers, as well as through distribution p...
Geratherm Medical Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
70
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.29M | 20.43M | 20.96M | 25.85M | 24.64M | 27.47M |
| Gross Profit | 5.96M | 12.78M | 6.27M | 6.38M | 16.32M | 17.60M |
| EBITDA | -1.94M | 2.95M | 4.18M | 3.37M | 2.20M | 4.35M |
| Net Income | 1.75M | 705.17K | 1.11M | 1.02M | 122.23K | 2.05M |
Balance Sheet | ||||||
| Total Assets | 27.53M | 28.54M | 35.72M | 38.38M | 34.56M | 35.99M |
| Cash, Cash Equivalents and Short-Term Investments | 9.61M | 9.64M | 7.74M | 10.89M | 6.47M | 10.26M |
| Total Debt | 2.62M | 3.28M | 7.23M | 9.29M | 9.32M | 10.40M |
| Total Liabilities | 6.95M | 7.71M | 13.11M | 16.15M | 15.93M | 16.07M |
| Stockholders Equity | 20.83M | 21.02M | 22.33M | 22.34M | 18.52M | 20.30M |
Cash Flow | ||||||
| Free Cash Flow | 2.68M | 1.23M | -212.00K | -133.00K | -353.00K | 1.14M |
| Operating Cash Flow | 2.79M | 1.87M | 1.43M | 2.61M | 917.00K | 3.92M |
| Investing Cash Flow | 3.89M | 3.82M | -2.09M | -767.00K | 3.00K | -3.79M |
| Financing Cash Flow | -2.43M | -2.69M | -3.09M | 4.35M | -3.52M | 684.00K |
Geratherm Medical Technical Analysis
Positive
2.86
Price Trends
2.76
Positive
2.98
Negative
3.22
Negative
Market Momentum
>-0.01
Negative
54.70
Neutral
61.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:GME, the sentiment is Positive. The current price of 2.86 is above the 20-day moving average (MA) of 2.71, above the 50-day MA of 2.76, and below the 200-day MA of 3.22, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 54.70 is Neutral, neither overbought nor oversold. The STOCH value of 61.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:GME.
Geratherm Medical Peers Comparison
UnderperformOutperform
Sector (55)
DE:GME
Geratherm Medical
2.80
-0.32
-10.34%
DE:AAQ1
aap Implantate
1.36
-0.32
-19.05%
DE:B8FK
Biofrontera
2.58
0.10
3.82%
DE:SBX
SynBiotic SE
2.01
-1.02
-33.66%
DE:BIG1
Bio-Gate AG
0.61
-0.16
-20.39%
DE:E8X
elexxion AG
0.07
-0.12
-62.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.